09
Feb
2010
PTC Therapeutics, Inc.: Series E $50M
Posted in I - Series E, Q - 4Q09, R - NORTH EAST, X - CF, X - Hemophilia, X - Muscular Dystrophy, XX - NJ
PTC Therapeutics (South Plainfield, NJ) a clinical-stage small molecule company focused on CF, hemophilia and muscular dystrophy, closed a $50M Series E financing. Participants include The Column Group, Delphi Ventures, CSFB Private Equity, HBM BioVentures and Novo Ventures.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb
25
Jan
2010
TriVascular, Inc.: Series B $30M
Posted in I - Series B, Q - 4Q09, R - WEST, X - Device (Stent), X – Device (Aneurysm), XX - CA
TriVascular (Santa Rosa, CA) a clinical-stage medical device company focused on transluminally placed endovascular stent grafts for abdominal and thoracic aortic disease, closed a $30M Series B financing. Participants include New Enterprise Associates, Delphi Ventures, MPM Capital and Kearny Venture Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb
OnBioVC PARTNERS
-
